Back to Search
JASON KONNER, MD
MD
Internal Medicine Physician
NPI: 1710958509IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
218209(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Research & Publications (12)
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
PMID 18554700·Gynecol Oncol·2008
3-trial
Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF Trap) to inhibit vascular endothelial growth factor activity.
PMID 15479484·Clin Colorectal Cancer·2004
4-observational
Pancreatic cancer: epidemiology, genetics, and approaches to screening.
PMID 12520639·Oncology (Williston Park)·2002
6-review
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
PMID 19110302·Gynecol Oncol·2009
8-other
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
PMID 19135708·Gynecol Oncol·2009
3-trial
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
PMID 18829514·Clin Cancer Res·2008
3-trial
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission.
PMID 19115680·Eur J Gynaecol Oncol·2008
3-trial
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.
PMID 18428210·Cancer·2008
8-other
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
PMID 18355690·Nucl Med Biol·2008
7-preclinical
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
PMID 17918264·Cancer·2007
3-trial
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
PMID 17634545·Clin Cancer Res·2007
8-other
Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
PMID 17023034·Gynecol Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3813
Quick Facts
- NPI
- 1710958509
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 12
Are you this provider?
Claim Your Profile